02268.HK
WuXi XDC Cayman Inc
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 67.90
−1.95%Margins
Gross margin
36.5%
EBITDA margin
30.8%
EBIT margin
27.7%
Net margin
22.4%
FCF margin
18.1%
13.6%
Return on equity
9.9%
Return on assets
16.1%
Return on invested capital
0.46x
Asset turnover
HKD 2.9B
Cash from operations
HKD 5.54
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026